dara-krd, autologous transplantation and mrd response-adapted consolidation and treatment cessation
Published 2 years ago • 404 plays • Length 5:41
Download video MP4
Download video MP3
Similar videos
-
2:04
dara-krd, transplant, and mrd response-adapted treatment in newly diagnosed myeloma
-
4:35
mrd-based dara-krd consolidation in patients with newly diagnosed multiple myeloma: master trial
-
5:32
master trial: dara-krd, asct & mrd-directed therapy in myeloma
-
3:07
master: dara-krd in patients with multiple myeloma
-
7:10
quadruplet induction therapy, asct and mrd-modulated consolidation and treatment cessation in ndmm
-
17:02
dara rvd in pts w/transplant eligible newly diagnosed multiple myeloma after 24 months maintenance
-
7:21
dara ird as extended induction and consolidation followed by lenalidomide maintenance
-
5:27
dara-krd with mrd-based response-adapted therapy in newly diagnosed myeloma
-
11:13
isatuximab, carfilzomib, lenalidomide, and dex (isa-krd) in pts with high-risk newly diagnosed mm
-
5:12
carfilzomib, lenalidomide and dex (krd) after asct results in high rates of mrd negativity
-
3:52
is dara being used in the frontline setting for myeloma patients?
-
48:26
daratumumab, carfilzomib, lenalidomide & dexamethasone w/ mrd res. adapted therapy in newly diag. mm
-
5:54
results of the phase 2 ifm 2018-04 study in high-risk, transplant-eligible ndmm patients
-
7:31
clinical trial: darzalex (daratumamab) with revlimid/velcade/dex for newly diagnosed myeloma
-
9:12
ird vs rd maintenance after autologous stem cell transplant in newly diagnosed multiple myeloma pts
-
2:04
next steps in myeloma: quadruplets, immunotherapy, and replacing transplant
-
3:43
what treatment is recommended for a newly diagnosed patient?
-
15:27
depth of response and mrd status in ultra high-risk mm: results of the uk optimum/muknine trial
-
3:52
analysis of the randomized forte trial in newly diagnosed multiple myeloma
Clip.africa.com - Privacy-policy